G. Bos

412 total citations
12 papers, 324 citations indexed

About

G. Bos is a scholar working on Pulmonary and Respiratory Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, G. Bos has authored 12 papers receiving a total of 324 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 5 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Surgery. Recurrent topics in G. Bos's work include Thyroid Disorders and Treatments (4 papers), Blood properties and coagulation (3 papers) and Trauma, Hemostasis, Coagulopathy, Resuscitation (2 papers). G. Bos is often cited by papers focused on Thyroid Disorders and Treatments (4 papers), Blood properties and coagulation (3 papers) and Trauma, Hemostasis, Coagulopathy, Resuscitation (2 papers). G. Bos collaborates with scholars based in Netherlands. G. Bos's co-authors include R. Docter, T. J. Visser, G Hennemann, E. P. Krenning, H.G. van Eijk, M.H. Otten, Steven J. Smith, G. Hennemann, J Gerbrandy and Durk Fekkes and has published in prestigious journals such as The Lancet, European Heart Journal and Clinica Chimica Acta.

In The Last Decade

G. Bos

10 papers receiving 298 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Bos Netherlands 7 183 71 52 49 43 12 324
J. P. Ardissone France 8 113 0.6× 68 1.0× 68 1.3× 49 1.0× 55 1.3× 9 385
María Ofelia Barber Fox Cuba 7 97 0.5× 75 1.1× 25 0.5× 78 1.6× 17 0.4× 19 332
Tomoko Saito Japan 8 121 0.7× 136 1.9× 33 0.6× 66 1.3× 32 0.7× 12 410
Marco Brogi Italy 11 186 1.0× 133 1.9× 20 0.4× 13 0.3× 29 0.7× 27 438
KAZURO KAISE Japan 13 239 1.3× 84 1.2× 16 0.3× 31 0.6× 21 0.5× 37 335
Michael B. Ranke Germany 7 345 1.9× 149 2.1× 16 0.3× 89 1.8× 107 2.5× 11 474
Kaj Siersbæk‐Nielsen Denmark 13 297 1.6× 54 0.8× 13 0.3× 23 0.5× 109 2.5× 22 410
G. Tonolo Italy 7 114 0.6× 39 0.5× 8 0.2× 16 0.3× 41 1.0× 19 317
Chang Soon Koh South Korea 10 171 0.9× 103 1.5× 10 0.2× 12 0.2× 57 1.3× 42 426
Kimberley Veraar Netherlands 7 46 0.3× 126 1.8× 27 0.5× 54 1.1× 110 2.6× 9 395

Countries citing papers authored by G. Bos

Since Specialization
Citations

This map shows the geographic impact of G. Bos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Bos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Bos more than expected).

Fields of papers citing papers by G. Bos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Bos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Bos. The network helps show where G. Bos may publish in the future.

Co-authorship network of co-authors of G. Bos

This figure shows the co-authorship network connecting the top 25 collaborators of G. Bos. A scholar is included among the top collaborators of G. Bos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Bos. G. Bos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Willems, Helmut, Martin den Heijer, Henk J. Blom, et al.. (1999). Hyperhomocysteinemie als risicofactor voor veneuze trombose.. Nederlandsch tijdschrift voor geneeskunde/Nederlands tijdschrift voor geneeskunde/NTvG-databank. 143(11). 552–556.
2.
Krenning, E. P., R. Docter, G. Bos, et al.. (1987). CELLULAR AND HUMORAL IMMUNITY IN PATIENTS WITH HYPERTHYROID GRAVES' DISEASE BEFORE, DURING AND AFTER ANTITHYROID DRUG TREATMENT. Clinical Endocrinology. 26(4). 385–394. 10 indexed citations
3.
Docter, R., G. Bos, E. P. Krenning, et al.. (1981). INHERITED THYROXINE EXCESS: A SERUM ABNORMALITY DUE TO AN INCREASED AFFINITY FOR MODIFIED ALBUMIN. Clinical Endocrinology. 15(4). 363–371. 59 indexed citations
5.
Docter, R., G. Bos, T. J. Visser, & G. Hennemann. (1980). THYROTROPHIN BINDING INHIBITING IMMUNOGLOBULINS IN GRAVES' DISEASE BEFORE, DURING AND AFTER ANTITHYROID THERAPY, AND ITS RELATION TO LONG‐ACTING THYROID STIMULATOR. Clinical Endocrinology. 12(2). 143–153. 44 indexed citations
6.
Hennemann, G, E. P. Krenning, M.H. Otten, et al.. (1979). RAISED TOTAL THYROXINE AND FREE THYROXINE INDEX BUT NORMAL FREE THYROXINE. The Lancet. 313(8117). 639–642. 100 indexed citations
7.
Smith, Steven J., G. Bos, J Gerbrandy, et al.. (1978). Lowering of serum 3,3‘,5‐triiodothyronine thyroxine ratio in patients with myocardial infarction; relationship with extent of tissue injury. European Journal of Clinical Investigation. 8(2). 99–102. 15 indexed citations
8.
Smith, S J, et al.. (1978). The influence of plasma volume changes on enzymatic estimation of infarct size.. PubMed. 12. 401–7.
9.
Smith, Steven J., et al.. (1977). Acute-phase proteins from the liver and enzymes from myocardial infarction; a quantitative relationship. Clinica Chimica Acta. 81(1). 75–85. 49 indexed citations
10.
Smith, Steven J., et al.. (1976). Liver reaction to tissue injury: Do therapeutic measures trigger the acute phase reaction?. Clinica Chimica Acta. 70(1). 127–132. 3 indexed citations
11.
Eijk, H.G. van, et al.. (1974). The relation of erythrocyte porphyrins to haemoglobin, haematocrit, transferrin and serum iron. Clinica Chimica Acta. 53(1). 35–42. 5 indexed citations
12.
Eijk, H.G. van, et al.. (1974). Measurement of the iron content in human liver specimens. Clinica Chimica Acta. 50(2). 275–280. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026